AHCC09
| AHCC09 |
A multi-national, double-blind, placebo-controlled, parallel randomized arms, phase II trial to compare the safety and efficacy of SIRT-Y90 followed by atezolizumab plus bevacizumab versus SIRT-Y90 followed by placebo in patients with locally advanced hepatocellular carcinoma (HCC) (STRATUM) (NCT05377034) |
|---|---|
| Status |
Recruiting |
| Contributing Principal Investigators and Centres |
Singapore Pierce Chow (National Cancer Centre), Toh Han Chong (National Cancer Centre), Chee Cheng Ean (National University Hospital) up to 11 overseas sites from: Taiwan (TBC) South Korea (TBC) China (TBC) |
| Protocol Chair |
Pierce Chow |